FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kelly Berg

Research Profile

Chemicals & Drugs

Physiology

Anatomy

Living Beings

Co-author Network

Publications

TOP 3
Kelly Berg; Lakshmi A Devi; Ivone Gomes; Achla Gupta; Kenneth Hargreaves; Blaine A McGuire; Philip S Portoghese; Matthew P Rowan; Teresa A Sanchez; Michelle Silva; William Clarke
Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons.
Kelly Berg; Kenneth Hargreaves; Stephen B Milam; Amol M Patwardhan; Matthew P Rowan; Teresa A Sanchez; Michelle Silva; William Clarke
Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.
Ruben Gomez; Kelly Berg; William Clarke; Marc J Glucksman; Elaine D Por; Nathaniel Jeske
Metallopeptidase inhibition potentiates bradykinin-induced hyperalgesia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kelly Berg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Kelly Berg; Lakshmi A Devi; Ivone Gomes; Achla Gupta; Kenneth Hargreaves; Blaine A McGuire; Philip S Portoghese; Matthew P Rowan; Teresa A Sanchez; Michelle Silva; William Clarke
Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons.
Molecular pharmacology 2012;81(2):264-72.
2011: Kelly Berg; Kenneth Hargreaves; Stephen B Milam; Amol M Patwardhan; Matthew P Rowan; Teresa A Sanchez; Michelle Silva; William Clarke
Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.
The Journal of pharmacology and experimental therapeutics 2011;338(1):92-9.
2011: Ruben Gomez; Kelly Berg; William Clarke; Marc J Glucksman; Elaine D Por; Nathaniel Jeske
Metallopeptidase inhibition potentiates bradykinin-induced hyperalgesia.
Pain 2011;152(7):1548-54.
2011: Nathaniel Jeske; Elaine D Por; Michael Henry; Armen Akopian; Sergei Belugin; Kelly Berg; Sraboni Chaudhury; Ruben Gomez
A-kinase anchoring protein 150 mediates transient receptor potential family V type 1 sensitivity to phosphatidylinositol-4,5-bisphosphate.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(23):8681-8.
2010: Matthew P Rowan; Kelly Berg; Stephen B Milam; Nathaniel Jeske; James Roberts; Kenneth Hargreaves; William Clarke
17beta-estradiol rapidly enhances bradykinin signaling in primary sensory neurons in vitro and in vivo.
The Journal of pharmacology and experimental therapeutics 2010;335(1):190-6.
2010: Vincent J Aloyo; Kelly Berg; William Clarke; Umberto Spampinato; John A Harvey
Inverse agonism at serotonin and cannabinoid receptors.
Progress in molecular biology and translational science 2010;91():1-40.
2009: José Brea; Marian Castro; Jesús Giraldo; Juan F López-Giménez; Juan Fernando Padín; Fátima Quintián; Maria Isabel Cadavid; Maria Teresa Vilaró; Guadalupe Mengod; Kelly Berg; William Clarke; Jean-Pierre Vilardaga; Graeme Milligan; M Isabel Loza
Evidence for distinct antagonist-revealed functional states of 5-hydroxytryptamine(2A) receptor homodimers.
Molecular pharmacology 2009;75(6):1380-91.
2009: Vincent J Aloyo; Kelly Berg; U Spampinato; William Clarke; John A Harvey
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
Pharmacology & therapeutics 2009;121(2):160-73.
2009: Matthew P Rowan; Nikita B Ruparel; Amol M Patwardhan; Kelly Berg; William Clarke; Kenneth Hargreaves
Peripheral delta opioid receptors require priming for functional competence in vivo.
European journal of pharmacology 2009;602(2-3):283-7.
2008: Kelly Berg; William Clarke; Kathryn A Cunningham; Umberto Spampinato
Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications.
Neuropharmacology 2008;55(6):969-76.
2008: Kelly Berg; John Dunlop; Teresa A Sanchez; Michelle Silva; William Clarke
A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling.
The Journal of pharmacology and experimental therapeutics 2008;324(3):1084-92.
2008: Kelly Berg; John A Harvey; Umberto Spampinato; William Clarke
Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression.
Progress in brain research 2008;172():287-305.
2007: Kelly Berg; Amol M Patwardhan; Teresa A Sanchez; Yamille M Silva; Kenneth Hargreaves; William Clarke
Rapid modulation of micro-opioid receptor signaling in primary sensory neurons.
The Journal of pharmacology and experimental therapeutics 2007;321(3):839-47.
2007: Pablo R Moya; Kelly Berg; Manuel A Gutiérrez-Hernandez; Patricio Sáez-Briones; Miguel Reyes-Parada; Bruce K Cassels; William Clarke
Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
The Journal of pharmacology and experimental therapeutics 2007;321(3):1054-61.
2007: Kelly Berg; Gustavo Zardeneta; Kenneth Hargreaves; William Clarke; Stephen B Milam
Integrins regulate opioid receptor signaling in trigeminal ganglion neurons.
Neuroscience 2007;144(3):889-97.
2006: Amol M Patwardhan; Anibal Diogenes; Kelly Berg; Jill C Fehrenbacher; William Clarke; Armen Akopian; Kenneth Hargreaves
PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor.
Pain 2006;125(1-2):114-24.
2006: Kelly Berg; Sylvia Navailles; Teresa A Sanchez; Yamille M Silva; Martyn D Wood; Umberto Spampinato; William Clarke
Differential effects of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone (SB 243213) on 5-hydroxytryptamine(2C) receptor-mediated responses.
The Journal of pharmacology and experimental therapeutics 2006;319(1):260-8.
2006: Nathaniel Jeske; Kelly Berg; Joanne C Cousins; Emer S Ferro; William Clarke; Marc J Glucksman; James Roberts
Modulation of bradykinin signaling by EP24.15 and EP24.16 in cultured trigeminal ganglia.
Journal of neurochemistry 2006;97(1):13-21.
2005: Kelly Berg; John A Harvey; Umberto Spampinato; William Clarke
Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors.
Trends in pharmacological sciences 2005;26(12):625-30.
2005: Amol M Patwardhan; Kelly Berg; Armen N Akopain; Nathaniel Jeske; Nikita Gamper; William Clarke; Kenneth Hargreaves
Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(39):8825-32.
2004: Margaret E Gnegy; Habibeh Khoshbouei; Kelly Berg; Jonathan A Javitch; William Clarke; Minjia Zhang; Aurelio Galli
Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
Molecular pharmacology 2004;66(1):137-43.
2004: Philippe De Deurwaerdère; Sylvia Navailles; Kelly Berg; William Clarke; Umberto Spampinato
Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(13):3235-41.
2004: Deborah M Holstein; Kelly Berg; L M Fredrik Leeb-Lundberg; Merle S Olson; Christine Saunders
Calcium-sensing receptor-mediated ERK1/2 activation requires Galphai2 coupling and dynamin-independent receptor internalization.
The Journal of biological chemistry 2004;279(11):10060-9.
2003: Kelly Berg; Kenda L J Evans; Jodie D Cropper; William Clarke
Temporal regulation of agonist efficacy at 5-hydroxytryptamine (5-HT)1A and 5-HT 1B receptors.
The Journal of pharmacology and experimental therapeutics 2003;304(1):200-5.
2002: Brian D Stout; William Clarke; Kelly Berg
Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence.
The Journal of pharmacology and experimental therapeutics 2002;302(3):957-62.
2001: Kelly Berg; William Clarke
Regulation of 5-HT(1A) and 5-HT(1B) receptor systems by phospholipid signaling cascades.
Brain research bulletin 2001;56(5):471-7.
2001: Kelly Berg; Brian D Stout; S Maayani; William Clarke
Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.
The Journal of pharmacology and experimental therapeutics 2001;299(2):593-602.
2001: Kelly Berg; Jodie D Cropper; Colleen M Niswender; Elaine Sanders-Bush; Ronald B Emeson; William Clarke
RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
British journal of pharmacology 2001;134(2):386-92.
2001: Kenda L J Evans; Jodie D Cropper; Kelly Berg; William Clarke
Mechanisms of regulation of agonist efficacy at the 5-HT(1A) receptor by phospholipid-derived signaling components.
The Journal of pharmacology and experimental therapeutics 2001;297(3):1025-35.
2001: William Clarke; Kelly Berg; Georgianna G Gould; Alan Frazer
Characterization of 5-HT(₁A,B) and 5-HT(₂A,C) serotonin receptor binding.
Current protocols in pharmacology / editorial board, S.J. Enna (editor-in-chief) ... [et al.] 2001;Chapter 1():Unit1.23.
1999: Kelly Berg; Brian D Stout; Jodie D Cropper; S Maayani; William Clarke
Novel actions of inverse agonists on 5-HT2C receptor systems.
Molecular pharmacology 1999;55(5):863-72.
1998: Kelly Berg; S Maayani; William Clarke
Interactions between effectors linked to serotonin receptors.
Annals of the New York Academy of Sciences 1998;861():111-20.
1998: Kelly Berg; S Maayani; J Goldfarb; William Clarke
Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists.
Annals of the New York Academy of Sciences 1998;861():104-10.
1998: Joanne Scalzitti; Kelly Berg; S A Kratowicz; Julie Hensler
Regulation of serotonin2A receptor expression by an antisense oligodeoxynucleotide.
Journal of neurochemistry 1998;71(4):1457-63.
1998: Kelly Berg; S Maayani; J Goldfarb; Clare Scaramellini; Paul Leff; William Clarke
Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
Molecular pharmacology 1998;54(1):94-104.
1996: Kelly Berg; S Maayani; William Clarke
5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.
Molecular pharmacology 1996;50(4):1017-23.
1995: Kelly Berg; S Maayani; R McKay; William Clarke
Nerve growth factor amplifies cyclic AMP production in the HT4 neuronal cell line.
Journal of neurochemistry 1995;64(1):220-8.
1994: Maria E Figueiredo-Pereira; Kelly Berg; Sherwin Wilk
A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell.
Journal of neurochemistry 1994;63(4):1578-81.
1994: Kelly Berg; William Clarke; C Sailstad; A Saltzman; S Maayani
Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
Molecular pharmacology 1994;46(3):477-84.
1994: Kelly Berg; William Clarke; Y Chen; B J Ebersole; R D McKay; S Maayani
5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms.
Molecular pharmacology 1994;45(5):826-36.
1993: B J Ebersole; Clement A Diglio; D W Kaufman; Kelly Berg
5-Hydroxytryptamine1-like receptors linked to increases in intracellular calcium concentration and inhibition of cyclic AMP accumulation in cultured vascular smooth muscle cells derived from bovine basilar artery.
The Journal of pharmacology and experimental therapeutics 1993;266(2):692-9.
1988: Kelly Berg; Howard R Petty
Cholesteryl ester handling by RAW264 macrophages: response to native and acetylated low density lipoprotein.
Molecular and cellular biochemistry 1988;84(1):29-40.
1988: Howard R Petty; Kelly Berg
Combinative ligand-receptor interactions: epinephrine depresses RAW264 macrophage antibody-dependent phagocytosis in the absence and presence of met-enkephalin.
Journal of cellular physiology 1988;134(2):281-6.
1987: H R Perry; Fox Bernard; Kelly Berg; Joe Francis
A monoclonal antibody (BMA-1) reactive with murine B cells as well as resident and elicited but not activated macrophages.
Immunology letters 1987;15(4):341-6.
1986: Kelly Berg; M L Berry; S A Sapareto; Howard R Petty
Fluorescence studies of macrophage recognition and endocytosis of native and acetylated low-density lipoprotein.
Biochimica et biophysica acta 1986;887(3):304-14.